Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 10;50(2):1602470.
doi: 10.1183/13993003.02470-2016. Print 2017 Aug.

Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease

Affiliations

Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease

Lies Lahousse et al. Eur Respir J. .

Abstract

Research on the association between chronic bronchitis and chronic obstructive pulmonary disease (COPD) exacerbations has led to discordant results. Furthermore, the impact of chronic bronchitis on mortality in COPD subjects is unclear.Within the Rotterdam Study, a population-based cohort study of subjects aged ≥45 years, chronic bronchitis was defined as having a productive cough for ≥3 months per year for two consecutive years. Linear, logistic regression and Cox proportional hazard models were adjusted for age, sex and pack-years.Out of 972 included COPD subjects, 752 had no chronic phlegm production (CB-) and 220 had chronic phlegm production, of whom 172 met the definition of chronic bronchitis (CB+). CB+ subjects were older, more frequently current smokers and had more pack-years than CB- subjects. During a median 6.5 years of follow-up, CB+ subjects had greater decline in lung function (-38 mL·year-1, 95% CI -61.7--14.6; p=0.024). CB+ subjects had an increased risk of frequent exacerbations (OR 4.0, 95% CI 2.7-5.9; p<0.001). In females, survival was significantly worse in CB+ subjects compared to CB- subjects. Regarding cause-specific mortality, CB+ subjects had an increased risk of respiratory mortality (hazard ratio 2.16, 95% CI 1.12-4.17; p=0.002).COPD subjects with chronic bronchitis have an increased risk of exacerbations and respiratory mortality compared to COPD subjects without chronic phlegm production.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Figures

FIGURE 1
FIGURE 1
Study flow. For additional cohort information see [23]. COPD: chronic obstructive pulmonary disease; RS: Rotterdam Study fourth examination in cohort I/second examination in cohort II/first examination in cohort III.
FIGURE 2
FIGURE 2
Kaplan–Meier curve of all-cause mortality according to chronic obstructive pulmonary disease without chronic bronchitis (CB, n=752) or with chronic bronchitis (CB+, n=172).
FIGURE 3
FIGURE 3
Major causes of death according to chronic obstructive pulmonary disease a) without chronic bronchitis (n=752) or b) with chronic bronchitis (n=172).

References

    1. Vestbo J, Hurd SS, Agustí AG, et al. . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347–365. - PubMed
    1. Agustí A, Bel E, Thomas M, et al. . Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 2016; 47: 410–419. - PubMed
    1. Celli BR, Decramer M, Wedzicha JA, et al. . An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir J 2015; 45: 879–905. - PubMed
    1. Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 228–237. - PMC - PubMed
    1. Mackay AJ, Hurst JR. COPD exacerbations: causes, prevention, and treatment. Med Clin North Am 2012; 96: 789–809. - PubMed

Publication types

MeSH terms